RS55695203 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (14)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Urine glycodeoxycholate 3-sulfate levels in chronic kidney disease | C | OR: 0.6 | 3E-50 | PubMed |
| Plasma taurodeoxycholic acid 3-sulfate levels in chronic kidney disease | C | OR: 0.48 | 5E-38 | PubMed |
| Plasma 1-oleoyl-GPG (18:1)* levels in chronic kidney disease | C | OR: 0.25 | 7E-38 | PubMed |
| Plasma X-24546 levels in chronic kidney disease | C | OR: 0.41 | 4E-36 | PubMed |
| Urine taurocholenate sulfate* levels in chronic kidney disease | C | OR: 0.41 | 5E-36 | PubMed |
| Urine taurodeoxycholic acid 3-sulfate levels in chronic kidney disease | C | OR: 0.49 | 1E-35 | PubMed |
| Lysophosphatidylinositol (20:4) [sn1] levels | C | OR: 0.35 | 1E-29 | PubMed |
| Lysophosphatidylinositol (20:4) [sn1] levels | C | OR: 0.32 | 1E-24 | PubMed |
| Urine X-21470 levels in chronic kidney disease | C | OR: 0.38 | 2E-22 | PubMed |
| Metabolite levels (eicosenedioate (C20:1-DC)) | C | OR: 0.36 | 4E-19 | PubMed |
| 1-eicosapentaenoyl-GPE (20:5) levels | C | OR: 0.12 | 9E-18 | PubMed |
| Urinary metabolite modules (eigenmetabolites) in chronic kidney disease | C | β: 0.009 | 1E-17 | PubMed |
| Urinary metabolite levels in chronic kidney disease | C | OR: 0.53 | 5E-17 | PubMed |
| Omega-6 fatty acid percentage of total fatty acids | C | β: 0.029 | 1E-11 | PubMed |